Search research articles
Contact Us
Filters
Showing results (131-140 of 187) with videos related to
Page
of 19
Sort By:
European Journal of Neurology
|
November 28, 2002
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta
A Paolillo, C Pozzilli, E Giugni, et al.
Neurology
|
November 28, 2001
Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of life
J A Freeman, A J Thompson, R Fitzpatrick, et al.
AJNR. American Journal of Neuroradiology
|
January 5, 1999
Sensitivity of enhanced MR in multiple sclerosis: effects of contrast dose and magnetization transfer contrast
S Bastianello, C Gasperini, A Paolillo, et al.
Journal of Computer Assisted Tomography
|
May 1, 1987
Simplified, noninvasive PET measurement of blood-brain barrier permeability
F Iannotti, C Fieschi, B Alfano, et al.
Biological Psychiatry
|
June 1, 1996
Involvement of the limbic system in multiple sclerosis patients with depressive disorders
U Sabatini, C Pozzilli, P Pantano, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
August 1, 1988
Remote effects of subcortical cerebrovascular lesions: a SPECT cerebral perfusion study
D Perani, V Di Piero, G Lucignani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 16, 1999
Interferon-beta-1a in relapsing-remitting multiple sclerosis: effect on hypointense lesion volume on T1 weighted images
C Gasperini, C Pozzilli, S Bastianello, et al.
Journal of Neurology
|
March 3, 2009
Intracortical excitability in patients with relapsing-remitting and secondary progressive multiple sclerosis
A Conte, D Lenzi, V Frasca, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
June 10, 1998
Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-beta1a
G Antonelli, F Bagnato, C Pozzilli, et al.
Neurology
|
October 26, 1999
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis
G Ristori, M G Buzzi, U Sabatini, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 187) with videos related to
Sort By:
Page
of 19
European Journal of Neurology
|
November 28, 2002
A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta
A Paolillo, C Pozzilli, E Giugni, et al.
Neurology
|
November 28, 2001
Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of life
J A Freeman, A J Thompson, R Fitzpatrick, et al.
AJNR. American Journal of Neuroradiology
|
January 5, 1999
Sensitivity of enhanced MR in multiple sclerosis: effects of contrast dose and magnetization transfer contrast
S Bastianello, C Gasperini, A Paolillo, et al.
Journal of Computer Assisted Tomography
|
May 1, 1987
Simplified, noninvasive PET measurement of blood-brain barrier permeability
F Iannotti, C Fieschi, B Alfano, et al.
Biological Psychiatry
|
June 1, 1996
Involvement of the limbic system in multiple sclerosis patients with depressive disorders
U Sabatini, C Pozzilli, P Pantano, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
August 1, 1988
Remote effects of subcortical cerebrovascular lesions: a SPECT cerebral perfusion study
D Perani, V Di Piero, G Lucignani, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 16, 1999
Interferon-beta-1a in relapsing-remitting multiple sclerosis: effect on hypointense lesion volume on T1 weighted images
C Gasperini, C Pozzilli, S Bastianello, et al.
Journal of Neurology
|
March 3, 2009
Intracortical excitability in patients with relapsing-remitting and secondary progressive multiple sclerosis
A Conte, D Lenzi, V Frasca, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
June 10, 1998
Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-beta1a
G Antonelli, F Bagnato, C Pozzilli, et al.
Neurology
|
October 26, 1999
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis
G Ristori, M G Buzzi, U Sabatini, et al.
Page
of 19